$36.55
-0.50 (-1.35%)
Par Pharmaceutical Companies, Inc. (NYSE:PRX)
CAPS Rating:
The Company, through its subsidiary Par Pharmaceutical, Inc., is engaged in the development, manufacture and distribution of generic pharmaceuticals and branded pharmaceuticals in the United States.
RSS Headlines
Fool UK